Clinical Trial Update: Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Treatment in Refractory Lupus Nephritis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated tacrolimus sustained-release capsules as induction therapy in refractory lupus nephritis. The update reports on the drug's efficacy an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Tacrolimus sustained-release capsules (Tacrolimus)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nephritis, Lupus | Phase 3 | Status: COMPLETED